Baylor Genetics Presents New Data on Clinical and
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) — Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic…
Baylor Genetics Presents New Data on Clinical and Diagnostic Utility of RNA Sequencing for Rare Disease at the American Society of Human Genetics 2025 Annual Meeting
Baylor Genetics Research underscores clinical utility of RNA sequencing in providing critical insights to drive diagnoses and medical…
Tempus AI, Inc. (TEM) Secures FDA Clearance for xR IVD Device to Enhance Drug Discovery
Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi stocks to buy right now. On September…
Using machine learning framework to identify prognostic biomarkers in neuroblastoma
Neuroblastoma is the most common solid tumor in infants and accounts for nearly 15% of all pediatric cancer-related…